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Abstract
Background Laparoscopic surgery for penetrating Crohn’s
disease (CD) still remains highly conflicting due to a lack
of sufficient data. Therefore, the following large study was
designed to compare postoperative outcomes after mini-
mal-invasive resections for penetrating and non-penetrating
CD.
Methods Consecutive patients, who underwent laparo-
scopic intestinal resection for symptomatic CD at a tertiary
academic referral center, were included. Patients were
divided according to perioperative findings in penetrating
and non-penetrating type of disease. All clinical data were
obtained from an institutional database and analyzed
retrospectively.
Results Of 234 patients enrolled, 101 patients [females:
n = 54 (53.5 %)] were operated on for non-penetrating CD
and 133 patients [females: n = 50 (37.6 %)] for penetrat-
ing CD. Fistulas (p\ 0.001), inflammatory mass
(p\ 0.001) and abscess formation (p\ 0.001) were
observed more frequently in the perforating group. Ileo-
colic resections were performed predominantly in both
groups [perforating CD: n = 110 (82.7 %), non-perforat-
ing CD: n = 82 (81.2 %)], with more complex resections
([1 intestinal resection) found in perforating CD
(p\ 0.001). Conversion rates did not differ significantly.
Notably, 30-day postoperative morbidity was comparable
for both groups [perforating CD: n = 20 (15 %), non-
perforating CD: n = 19 (18.8 %), p = 0.44]. Postoperative
complication rates graded according to the Clavien–Dindo
classification showed no difference too (p = 0.49).
Conclusion Laparoscopic surgery can be conducted safely
in selected patients with penetrating CD without increasing
the risk of postoperative complications. This finding needs
to be implemented in future guidelines.
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Crohn’s disease (CD) represents a challenging chronic
inflammatory disorder, which is associated with an inci-
dence of up to 20.2 per 100,000 in Northern America and
Europe [1, 2]. The Vienna and Montreal classification
systems subdivide disease behavior into either penetrating
or stricturing or non-penetrating, non-stricturing pheno-
types [3]. Greenstein et al. [4] described penetrating CD
(PCD), characterized by acute perforation, chronic fistula
or abscess formation, as a distinct aggressive type, which
influences interval to reoperation. Recently, Niewadomski
et al. [5] showed that penetrating disease, although treated
by modern immunosuppressive medication, is still associ-
ated with a more severe course of disease. Given that
typical features of penetrating disease are established risk
factors for postoperative complications and adverse short-
term outcomes in surgery, the question arises whether
minimal-invasive surgery is an appropriate approach for
PCD [6, 7].
Laparoscopic surgery is the treatment of choice for non-
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less surgical trauma, earlier bowel function, less postop-
erative pain and shorter hospital stay when compared to
open procedures [8, 9].
Nevertheless, technical difficulties such as the presence
of inflammatory mass and bowel fistulas challenge the
widespread use of the laparoscopic approach in complex
CD resections. Additionally, Alves et al. [10] delineated
that penetrating disease and preoperative immunosuppres-
sive regimen increased the likelihood of conversion.
Notably, current guidelines limit minimal-invasive tech-
niques or even do not recommend laparoscopic resection as
first-line treatment in penetrated CD due to insufficient data
[11, 12].
Hereby, we present the largest study to date comparing
outcomes of laparoscopic resection for penetrating and
non-penetrating disease.
Materials and methods
Consecutive patients, who underwent laparoscopic intesti-
nal resections for symptomatic CD, were enrolled at a
tertiary academic referral center between 1997 and 2012.
Patients were divided according to perioperative findings
and histological results in either penetrating or non-pene-
trating disease behavior. Penetrating phenotype was
defined as acute free perforation, chronic perforation with
fistula or abscess formation [4], whereas other operated
patients were grouped as non-penetrating.
All minimal-invasive resections were conducted or
supervised by experienced consultants, who are specialized
in the treatment of CD. The surgical procedure was already
described elsewhere in detail [13]. Briefly, after laparo-
scopic bowel mobilization exteriorization was performed
through a 4–6 cm vertical periumbilical incision. Mesen-
teric vessel ligation, resection and anastomotic recon-
struction were conducted extracorporeally. Conversion was
defined as extension of planned incision (4–6 cm).
In 1997 at the beginning of the implementation of
laparoscopic surgery for CD, a strict selection policy was
performed. With increasing experience, even previous
abdominal operations and complex cases were not regarded
as contraindication for a minimal-invasive approach.
Demographic and relevant clinical data were extracted
from an institutional database and individual chart review,
respectively. The institutional review board approved the
study protocol.
Next to baseline characteristics, we documented intra-
operative findings and previous abdominal operations for
CD. Steroid therapy was defined as the use of corticos-
teroids until the day before surgery. Those patients who
received steroids preoperatively but stopped treatment at
least 2 days before surgery were considered as ‘‘non
steroids.’’ The exposure to azathioprine/6-mercaptopurine
(AZA/6MP) before surgery was defined as the intake of
AZA/6MP within 2 weeks preoperatively. The adminis-
tration of anti-TNF antibody was documented within
1 week before operation. Resections were also divided into
simple (1 intestinal resection) and complex ([1 intestinal
resection).
Thirty-day morbidity was assessed by using the Cla-
vien–Dindo Score [14]. In addition, complications were
grouped into surgical and medical complications.
Statistical analysis
Continuous data are shown as mean ± SD if normally
distributed or as median and minimum–maximum other-
wise. Categorical variables are described with absolute
numbers and percentages and were tested by v2 test. In case
of ordered categories, a trend version of the v2 test was
used. Furthermore, an exact version of the v2 test was used
if requirements for an asymptotic v2 test were not fulfilled.
T tests were performed to compare means between two
groups in case of normally distributed data and the Wil-
coxon rank-sum test for skewed variables or in the pres-
ence of outliers. All p values were two-sided, and p B 0.05
was considered statistically significant. All calculations
were performed with SAS version 9.3 (SAS Institute Inc.,
Cary, NC, USA).
Results
During the study period, 461 patients underwent surgery of
CD. Two hundred and thirty-four (50.8 %) patients were
operated on laparoscopically and were included for further
analysis. A total of 133 patients (56.8 %) were assigned to
the PCD group, and 101 patients (43.2 %) suffered from
NPCD.
In the PCD group, a significantly higher number of male
patients (n = 83, 62.4 %) were observed in contrast to
patients with NPCD (n = 47, 46.5 %, p = 0.02). Further
demographic data were comparable between both groups
and are listed in Table 1.
Intraoperative findings were significantly different
between both groups in terms of the presence of inflam-
matory mass [PCD: n = 85 (63.9 %), NPCD: n = 14
(13.9 %), p\ 0.0001], fistula [PCD: n = 118 (88.7 %),
NPCD: n = 0, p\ 0.0001] and abscess formation [PCD:
n = 43 (32.3 %), NPCD: n = 0, p\ 0.0001]. Addition-
ally, patients with PCD underwent a higher number of
complex [PCD: n = 55 (41.7 %), NPCD: n = 15 (14.9),
p\ 0.001] and colonic resections (p = 0.002, Table 2),
which also was reflected by a longer postoperative hospital
stay [PCD: 8 days (3–22), NPCD: 8 days (5–45),
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p = 0.033]. Operative time was comparable between
groups [PCD: 135 (60–370) min, NPCD: 130 (50–360)
min, p = 0.89).
Conversion rates tended to be higher when CD behaved
penetrating [n = 22 (6.5 %) vs. n = 10, (9.9 %);
p = 0.18], but failed to reach statistical significance. In the
PCD group, conversion to open surgery was conducted
because of inflammatory adhesions (n = 9, 40.9 %), large
inflammatory mass (n = 7, 31.8 %), lack of anatomical
clarity (n = 2, 9.1 %), severe fistula (n = 2, 9.1 %), bowel
perforation (n = 1, 4.5 %) and bleeding (n = 1, 4.5 %).
Reasons for conversions in the NPCD group were inflam-
matory adhesions (n = 7, 70 %), lack of anatomical clarity
(n = 2, 20 %) and bleeding (n = 1, 10 %).
Postoperative complications
There were no deaths after laparoscopic surgery for CD.
Surgical and medical complications did not differ
between both groups (p = 0.39). In the PCD group, 20
(15 %) postoperative complications were observed
[medical: n = 9 (6.8 %), surgical: n = 11 (8.3 %)]. Med-
ical events were paralytic ileus (n = 4), fever of unknown
origin (n = 3), pneumonia (n = 1) and cardiac arrhythmia
(n = 1). Surgical complications were composed of anas-
tomotic leakage (n = 4), wound infection (n = 4), post-
operative bleeding (n = 2) and intra-abdominal abscess
formation (n = 1).
In the NPCD group, 19 (18.8 %) postoperative events
[medical complications: n = 12 (11.9 %), surgical com-
plications: n = 7 (6.9 %)] were found. Medical compli-
cations included fever of unknown origin (n = 5), paralytic
ileus (n = 4), urinary tract infection (n = 2) and pneu-
monia (n = 1), whereas anastomotic leakage (n = 3),
mechanic bowel obstruction (n = 1), wound infection
(n = 1), intra-abdominal abscess without leakage (n = 1)
and bowel perforation due to drain arrosion (n = 1)
accounted for surgical events, respectively.
Postoperative complications defined according to the
Clavien–Dindo classification showed no significant differ-
ence between both groups (p = 0.49) and are further out-
lined in Table 3.
Table 1 Demographic data of patients with penetrating and non-penetrating Crohn’s disease (CD)
Penetrating Crohn’s disease Non-penetrating Crohn’s disease
Patients 133 (56.8) 101 (43.2)
Age 32.6 (±11.6) 35.2 (±12.4) NS
Sex
Female 50 (37.6) 54 (53.5)
Male 83 (62.4) 47 (46.5) p = 0.02
BMI 22 (±4.5) 21.5 (±3.6) NS
Age at CD diagnosis 23 (10–56) 25.5 (9–76) NS
Smoking 68 (52.7) 50 (50.5) NS
Azathioprine/6-mercaptopurine 21 (15.8) 23 (22.8) NS
Corticosteroids 28 (21.1) 16 (15.8) NS
Anti-TNF antibodies 0 3 (3) NS
Previous CD surgery 16 (12) 27 (26.7) p = 0.004
Table 2 Comparison of type of
resection and anastomosis
between penetrating and non-
penetrating Crohn’s disease
Penetrating Crohn’s disease Non-penetrating Crohn’s disease
Type of resection
Ileocolic 110 (82.7) 82 (81.2) NS
Small bowel 14 (10.5) 14 (13.7) NS
Colonic 34 (25.6) 11 (10.9) p = 0.002
Rectal 1 (0.8) 0 NS
Anastomoses
Stapled 89 (66.9) 71 (70.3) NS
Handsewn 39 (29.3) 30 (29.7) NS
Both 5 (3.8) 0 NS
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Discussion
To our knowledge, this is the largest study comparing the
outcomes of laparoscopic surgery for penetrating versus non-
penetrating CD. We could demonstrate that despite more
aggressive clinical behavior, which was also reflected by more
complex resections and a longer hospital stay, 30-day mor-
bidity was not elevated in patients with perforated CD. Nev-
ertheless, surgeons have to be aware that they are confronted
with a trend to higher conversion rates in PCD.
Evidence of a distinct aggressive pattern in CD was already
observed by Greenstein et al. [4] in 1988. Independent of
anatomical localization, it was noticed that PCD retained its
penetrating identity even after surgical resections. Impor-
tantly, phenotypic characteristics of PCD were also linked to
postoperative complications and adverse short-term course.
Alves et al. [15] revealed abscess formation, recurrent
CD episode, preoperative steroid use and poor nutritional
status as risk factors for intra-abdominal septic complica-
tions after primary elective ileocolic resection. Kanazawa
et al. [6] demonstrated that these findings were also
responsible for recurrent interventions. They reviewed 550
patients from which 88.6 % underwent open and 11.4 %
laparoscopic operations for primary and recurrent CD and
confirmed PCD as a risk factor for postoperative septic
complications. Furthermore, a high level of C-reactive
protein, reflecting increased disease activity, a low level of
preoperative hemoglobin and recurrent disease were high-
lighted as marker for an eventful postoperative course in
laparoscopic CD surgery [13, 16, 17].
Deviation of planned operative approach is another
important aspect in minimal-invasive surgery. Expert
centers report conversion rates between 0 and 29 % in CD
surgery [9]. Interestingly, Mino et al. [18] observed that
fistulas and abscesses predicted conversion and suggested
preoperative imaging as a tool to select patients without
signs of PCD for laparoscopic interventions.
Consequently, current guidelines implemented those
limited results about laparoscopic surgery in PCD. The
European Crohn’s and Colitis Organisation (ECCO) stated
that in complex cases or recurrent situations insufficient
evidence exists to recommend laparoscopic surgery as
technique of first choice [11]. In contrast, the American
Society of Colon and Rectal Surgeons (ASCR) clarifies that
a minimal-invasive approach in PCD is feasible if appro-
priate expertise is available although this recommendation
is mainly based on a study with only 40 patients presenting
PCD [12, 19, 20].
Previous reports about outcomes of surgery on PCD
mainly focused on open resections or consisted of a small
selected population of primary laparoscopic ileocolic
resections [9, 21]. Thus, large comparative studies on
minimal-invasive surgery in PCD are scarce.
Wu et al. [22] investigated laparoscopic-assisted ileo-
colic resections in CD and compared patients with abscess
or phlegmon to recurrent disease and to patients that had an
uncomplicated course of disease. Perioperative morbidity,
conversion to an open procedure and operative times were
comparable between minimal-invasive groups. Length of
hospitalization was significantly shorter when laparoscopic
approach was compared to a control group of 70 open
resections. However, only 14 patients were classified to
have an abscess or phlegmon, which limited the informa-
tion on penetrating disease behavior.
Remarkably, Nguyen et al. [23] expanded information on
outcomes of laparoscopic resections in CD. They retro-
spectively analyzed 335 minimal-invasive procedures by a
single surgeon, which revealed a conversion rate of only 2 %
and postoperative complications in 13 %. Though approxi-
mately one-third of the population was affected by PCD,
results were not differentiated by type of disease behavior.
Interestingly, we noticed a longer postoperative hospital
stay in the PCD cohort, which is concordant with a recent
study that compared outcomes of PCD versus NPCD [24].
Bellolio et al. analyzed 293 patients with perforating CD,
which were compared to 141 non-perforating phenotypes.
Perforating phenotype was less likely to undergo laparo-
scopic procedure and developed more postoperative
abscesses, but general morbidity was similar between
groups. Nevertheless, results should be extrapolated with
caution, because open and minimal-invasive techniques
were mixed in both groups, and therefore information on
laparoscopic outcomes in PCD should be interpreted
carefully.
Few limitations of the study need to be addressed.
Although the current analysis includes a high number of
Table 3 Postoperative
morbidity after laparoscopic
resection in Crohn’s disease
according to the Clavien–Dindo
classification
Penetrating Crohn’s disease Non-penetrating Crohn’s disease
No complications 113 (85) 82 (81.2) NS
Grade I 8 (6) 4 (4)
Grade II 4 (3) 9 (8.9)
Grade IIIa 2 (1.5) 0
Grade IIIb 6 (4.5) 5 (4.9)
Grade IV 0 1 (1)
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patients, the study was designed retrospectively; thus,
selection bias cannot be ruled out. Our aim is to treat the
majority of CD patients by using a minimal-invasive
approach; however, patients with previous laparotomies in
association with penetrating disease are still often managed
by laparotomy. In contrast, those patients with a previous
laparoscopic approach are initially attempted to be treated
minimal invasive again even if a penetrating disease is
expected. As a consequence, careful patient selection is
crucial in order to achieve best outcome.
Conclusion
In the present large series, we could clearly demonstrate
that laparoscopic surgery is safe and feasible in perforating
CD without an increased number of complications in
comparison with non-perforating CD. This finding should
be taken into account in future guidelines. Notably,
laparoscopic surgery remains challenging in this group of
patients; thus, careful patient selection and surgical expe-
rience is essential.
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